Anticoagulants, Antithrombotics, and Antiplatelets

  • Phuong-Tan Nguyen
  • Jessica Erin Sandy
  • Ricardo Munoz

Alteplase is used for treatment of acute myocardial infarction (MI), acute ischemic stroke, acute, massive pulmonary embolism, and occluded central venous catheters. Alteplase has also been used in pediatric patients with systemic thrombosis.


International Normalize Ratio Kawasaki Disease Tranexamic Acid Thrombotic Thrombocytopenic Purpura Complete Blood Cell Count 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Monagle P, Chan A, Massicotte P, et al. Antithrombotic therapy in children: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 645S–687S.PubMedCrossRefGoogle Scholar
  2. 2.
    Monagle P, Michelson AD, Bovill E, et al. Antithrombotic therapy in children. Chest 2001; 119: 344S–370S.PubMedCrossRefGoogle Scholar
  3. 3.
    Balaguru D, Dilawar M, Ruff P, Radtke WA. Early and late results of thrombolytic therapy using tissue-type plasminogen activator to restore arterial pulse after cardiac catheterization in infants and small children. Am J Cardiol 2003; 91(7): 908–910.PubMedCrossRefGoogle Scholar
  4. 4.
    Duncan BW, Hraska V, Jonas RA, Wessel DL, del Nido PJ, Laussen PC, MayerJE, Lapierre RA, Wilson JM. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg 1999; 117: 529–542.PubMedCrossRefGoogle Scholar
  5. 5.
    Wilson JM, Bower LK, Fackler, JC, Beals DA, Berhus BO, Kevy SB. Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg 1993; 28: 536–541.PubMedCrossRefGoogle Scholar
  6. 6.
    Horwitz JR, Cofer BR, Warner BH, Cheu HW, Lally KP. A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. J Pediatric Surg 1998; 33: 1610–1613.CrossRefGoogle Scholar
  7. 7.
    Thompson, CA. Don’t give aprotinin again within 12 months, FDA says. American Society of Health System Pharmacists December 15, 2006.Google Scholar
  8. 8.
    Lexi-comp© 1978–2007; Poison and Toxicology.Google Scholar
  9. 9.
    Hursting MJ, Dubb J, Verme-Gibboney CN. Argatroban anticoagulation in pediatric patients. A literature analysis. J Pediatr Hematol Oncol 2006; 28: 4–10.PubMedCrossRefGoogle Scholar
  10. 10.
    John TE, Jallisey RK. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia. Pharmacother 2005; 25: 1383–1388.CrossRefGoogle Scholar
  11. 11.
    Israels SJ, Michelson AD. Antiplatelet therapy in children. Thrombosis Research 2006; 118: 75–83.PubMedCrossRefGoogle Scholar
  12. 12.
    Macdonald S. Aspirin use to be banned under 16 year olds. BMJ 2002; 325: 988.PubMedCrossRefGoogle Scholar
  13. 13.
    Finkelstein Y, Nurmohamed L, Avner M, Benson LM, Koren G. Clopidogrel use in children. J Pediatr 2005; 147: 657–661.PubMedCrossRefGoogle Scholar
  14. 14.
    Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G. The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 2006; 37: 1120–1122.PubMedCrossRefGoogle Scholar
  15. 15.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747–2771.PubMedCrossRefGoogle Scholar
  16. 16.
    Lexi-Comp© 1978–2007; Pediatic Lexi-Drugs.Google Scholar
  17. 17.
    Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, deVeber G, Leaker M, Chan AK, Massicotte MP. The use of low-molecular-weight heparin in pediatric patients: A prospective cohort study. J Pediatr 2000; 136: 439–445.PubMedCrossRefGoogle Scholar
  18. 18.
    Schmidt B, Ofosu FA, Mitchell L, Brooker LA, Andrew M. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res 1989; 25: 405–408.PubMedCrossRefGoogle Scholar
  19. 19.
    Gershanik J, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982; 307: 1384–1388.PubMedCrossRefGoogle Scholar
  20. 20.
    Cobel-Geard RJ, Hassouna HI. Interaction with protamine sulfate with thrombin. Am J Hematol 1983; 14: 227–233.PubMedCrossRefGoogle Scholar
  21. 21.
    Lee C, Nechyba C, Gunn VL, Drug doses. Gunn VL, Nechyba C. The Harriet Lane Handbook. Philadelphia; Mosby, 2002.Google Scholar
  22. 22.
    Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997; 84: 990–996.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2008

Authors and Affiliations

  • Phuong-Tan Nguyen
    • 1
  • Jessica Erin Sandy
    • 2
  • Ricardo Munoz
    • 3
  1. 1.General Pediatrics School of PharmacyChildren's Hospital of PittsburghPittsburghUSA
  2. 2.Neonatal Intensive Care School of PharmacyChildren's Hospital of PittsburghPittsburghUSA
  3. 3.Critical Care Medicine, Pediatrics and SurgeryChildren's Hospital of Pittsburgh of UPMCPittsburghUSA

Personalised recommendations